Piper Jaffray analyst William Quirk upgraded Meridian Biosciences (NASDAQ: VIVO) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change Upgrades

Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending AcquisitionApril 30, 2019 10:38 AM Meridian Bioscience (VIVO) to Acquire Business of GenePOCApril 30, 2019 9:41 AM Meridian Bioscience (VIVO) Tops Q2 EPS by 3cApril 30, 2019 8:32 AM